Abstract
AIM:
To evaluate the clinical impact of the use of the Caiman® articulating energy device in advanced ovarian cancer (AOC) including rectosigmoid resection [e.g. modified posterior exenteration (MPE)].
PATIENTS AND METHODS:
This was a prospective single-institution observational study with women undergoing MPE where all soft-tissue dissections and vessel ligations were performed using the Caiman® device. Intraoperative and postoperative surgical data were collected. Bladder function after nerve-sparing surgery was analyzed before and 6 months after surgery.
RESULTS:
Forty patients were registered in the study. The median time for specimen removal using Caiman® was 86 min (range=70-120 min). Major vessel ligation was successful in all patients with a median of a single (range=1-4) Caiman® application to seal major vessels. No intraoperative or postoperative complications or bladder dysfunctions associated with the use of Caiman® were noted.
CONCLUSION:
Caiman® can be safely used in AOC surgery and may save time through faster dissection. However, comparative studies with other energy devices are needed to confirm this finding.
Lingua originale | English |
---|---|
pagine (da-a) | 359-364 |
Numero di pagine | 6 |
Rivista | In Vivo |
Volume | 32 |
DOI | |
Stato di pubblicazione | Pubblicato - 2018 |
Keywords
- Adult
- Aged
- Analysis of Variance
- Colectomy
- Female
- Gynecologic Surgical Procedures
- Humans
- Intraoperative Complications
- Middle Aged
- Neoplasm Staging
- Ovarian Neoplasms
- Ovarian cancer
- Postoperative Complications
- Retreatment
- Treatment Outcome
- energy device
- surgery